Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Current Hematologic Malignancy Reports
|
March 14, 2012
Curing chronic myeloid leukemia
Delphine Rea, Philippe Rousselot, Joelle Guilhot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia
Frédéric Millot, Natacha Maledon, Joelle Guilhot, et al.
Pediatrics
|
July 5, 2005
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia
Frédéric Millot, Philippe Traore, Joelle Guilhot, et al.
Journal of Pediatric Hematology/Oncology
|
March 21, 2002
Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia
Frédéric Millot, Pauline Brice, Noel Philippe, et al.
Cancer
|
October 10, 2013
Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia
Hyacinthe Johnson-Ansah, Joelle Guilhot, Philippe Rousselot, et al.
Pediatric Blood & Cancer
|
December 1, 2005
Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia
Frédéric Millot, Joelle Guilhot, Brigitte Nelken, et al.
American Journal of Hematology
|
September 19, 2012
Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study
Philippe Rousselot, Pascale Cony-Makhoul, Franck Nicolini, et al.
Blood
|
March 24, 2012
The EUTOS CML score aims to support clinical decision-making
Verena Hoffmann, Michele Baccarani, Joerg Hasford, et al.
Blood
|
May 4, 2011
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
Joerg Hasford, Michele Baccarani, Verena Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2020
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study
Deborah Meyran, Arnaud Petit, Joelle Guilhot, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Current Hematologic Malignancy Reports
|
March 14, 2012
Curing chronic myeloid leukemia
Delphine Rea, Philippe Rousselot, Joelle Guilhot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia
Frédéric Millot, Natacha Maledon, Joelle Guilhot, et al.
Pediatrics
|
July 5, 2005
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia
Frédéric Millot, Philippe Traore, Joelle Guilhot, et al.
Journal of Pediatric Hematology/Oncology
|
March 21, 2002
Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia
Frédéric Millot, Pauline Brice, Noel Philippe, et al.
Cancer
|
October 10, 2013
Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia
Hyacinthe Johnson-Ansah, Joelle Guilhot, Philippe Rousselot, et al.
Pediatric Blood & Cancer
|
December 1, 2005
Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia
Frédéric Millot, Joelle Guilhot, Brigitte Nelken, et al.
American Journal of Hematology
|
September 19, 2012
Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study
Philippe Rousselot, Pascale Cony-Makhoul, Franck Nicolini, et al.
Blood
|
March 24, 2012
The EUTOS CML score aims to support clinical decision-making
Verena Hoffmann, Michele Baccarani, Joerg Hasford, et al.
Blood
|
May 4, 2011
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
Joerg Hasford, Michele Baccarani, Verena Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2020
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study
Deborah Meyran, Arnaud Petit, Joelle Guilhot, et al.
Page
of 3